Clinical significance of perineural invasion by prostate cancer

Published Date: 08 Mar 2023

This study examines the clinical impact of unilateral perineural invasion in prostate cancer. How does unilaterality affect long-term oncology outcomes?

Read Full News

Latest News

What the 'Relax Your Tight End' Super Bowl Ad Got Wrong

PSA tests are never 'simple.' Dr Kenny Lin discusses how to move beyond overdiagnosis toward truly informed prostate cancer screening.

EoE on the Rise: What Every Endoscopist Should Know

Dr David Johnson highlights the recommendations most likely to change how you endoscopically manage this increasingly prevalent disease.

Staying the Course After EGFR Progression

Dr Mark Kris highlights a recent study on osimertinib in NSCLC and outlines the best approaches for treatment beyond progression.

AI in Medicine Desperately Needs Less Hype and More Honesty

A Yale School of Medicine professor argues that total transparency is the only way AI can become a trustworthy tool for physicians and patients.

When Patients Feel Unheard: The Communication Gap in Care

Dr Mark Lewis discusses a recent social-media post which led to a reflection on how physicians can actively listen to patients and facilitate shared decision making.

Todays Updates

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

Long-acting injectable antipsychotics are linked to lower rehospitalization rates than oral antipsychotics in patients with bipolar I disorder, a study shows.

MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

Todays Updates

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

Long-acting injectable antipsychotics are linked to lower rehospitalization rates than oral antipsychotics in patients with bipolar I disorder, a study shows.

MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

Latest News

PSA tests are never 'simple.' Dr Kenny Lin discusses how to move beyond overdiagnosis toward truly informed prostate cancer screening.

Dr David Johnson highlights the recommendations most likely to change how you endoscopically manage this increasingly prevalent disease.

Dr Mark Kris highlights a recent study on osimertinib in NSCLC and outlines the best approaches for treatment beyond progression.

A Yale School of Medicine professor argues that total transparency is the only way AI can become a trustworthy tool for physicians and patients.

Dr Mark Lewis discusses a recent social-media post which led to a reflection on how physicians can actively listen to patients and facilitate shared decision making.

News All Time

HF With Improved Ejection Fraction

Heart Failure with Improved ejection fraction is characterized by previously reduced left ventricular ejection fraction (≤40%) that subsequently improves to >40%. This review highlight existing clinical gaps and proposes future research directions to refine risk stratification and therapeutic approaches for this evolving HF population.

S2 Episode 6: A Futuristic Vision for Treating Myelofibrosis

What will the next decade bring for myelofibrosis care? Drs Jain and Pemmaraju explore futuristic therapies, earlier interventions, and smarter diagnostics.

Radiofrequency Ablation: A First-Line Treatment Option

Drs Kaniksha Desai and Iram Hussain discuss the use of radiofrequency ablation for the treatment of hyperthyroidism.

S2 Episode 5: DNA Repair and Replication Stress in Endometrial Cancer

Drs Ursula A. Matulonis and Joyce F. Liu discuss targeting DNA damage and repair and replication stress in endometrial cancer.

May 09 2025 This Week in Cardiology

The controversial KETO-CTA study, tough decisions in subclinical AF, and another potentially huge benefit for GLP-1 agonist drugs are discussed by John Mandrola, MD, in this week’s podcast.

Should All Newborns Be Screened for Congenital Hypothyroidism?

Drs Kaniksha Desai and Larry Fox discuss congenital hypothyroidism, including when to test and how to treat it.

S2 Episode 4: Immunotherapy Insights and Research in Endometrial Cancer

Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

USCAP 2025

Read clinically focused news coverage of key developments from USCAP 2025

S3 Episode 3: The 2025 updates of the American Diabetes Association

Drs Carol H. Wysham and Rozalina G. McCoy discuss the 2025 updates of the American Diabetes Association, including comorbidities, dental care, sexual dysfunction, and CGM use.

Episode 2: New Guidelines and the Lupus Nephritis Kidney Conundrum

Join Drs Maureen McMahon and Brad Rovin as they discuss the KDIGO, ACR and EULAR guidelines as they relate to lupus nephritis.

Episode 1: Lupus by the Numbers: What the Data Reveals

Join Drs Maureen McMahon and Peter Izmirly as they discuss lupus epidemiology, and why knowing the data is especially important for physicians on the frontlines of healthcare.

S2 Episode 3: Molecular Classification and Genetics of Endometrial Cancer

Drs Ursula A. Matulonis and Katherine Fuh discuss the molecular classification and genetics of endometrial cancer as well as when to rebiopsy, research updates, and what's to come in the future.

The Interpretation and Management of Hypocalcemia

Mood change, neuropsychiatric symptoms, muscle cramps, or spasm are common in patients with this condition.

S2 Episode 2: Diet, Exercise, and Myelofibrosis: A Holistic Approach

Join Drs Tania Jain and Krisstina Gowin as they discuss the role integrative medicine plays in the treatment of myelofibrosis.

S3 Episode 1: MASLD and Type 2 Diabetes: Screening and Management

Drs Carol H. Wysham and Scott Isaacs discuss incorporating the screening and management of metabolic dysfunction-associated steatotic liver disease in endocrine practice.

Spinal Muscular Atrophy: 5 Things to Know

SMA ranges from mild with slow progression to severe with loss of life in childhood. These five things to know are crucial to understanding the types, causes, diagnosis, and latest treatments.

Recommended News For You

Treatment of Oligometastatic EGFR-Mutant Lung Cancer

Immunotherapy in Head and Neck Cancer After Failure of Definitive Therapy.

A specific drug combination is being tested in a clinical trial for the deadly brain cancer glioblastoma.

Patients value communication skills from cancer surgeons across six key areas, according to research

Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities

Adopted cancer cells and the effects of their presence.

Healthy weight loss could lower your odds for cancer

Recommended Articles For You

Understanding Axitinib: What You Need To Know For Your Treatment Plan 

Ultrasound: A Promising Tool in the Fight Against Malignant Breast Cancer 

Revolutionizing Cancer Treatment with Trilaciclib: How a New Drug is Transforming Outcomes 

Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Obesity-associated cancers tripled nationwide over past two decades

2.

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

3.

Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.

4.

Insurance Claim Denials for Preventive Care More Common in At-Risk Patients

5.

Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type

1.

Decoding Granular Cell Tumor: What You Need to Know

2.

Is AI The New Radiologist For Breast MRI?

3.

Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication

4.

All About Ferric Gluconate – The Best Source Of Iron For Anemia

5.

Discovering the Benefits of TNK: A Comprehensive Blog Article 

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV

3.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

4.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

5.

Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot